Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICV Valproate in Refractory Focal Epilepsy
NCT02899611Phase 2Completed
- Sponsor
- Cerebral Therapeutics
- Start
- Aug 2016
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in Focal Epilepsy (FE), sponsored by Cerebral Therapeutics. Started Aug 2016; status: completed.
02
Drugs
valproic acid
03
Conditions
Focal Epilepsy (FE)
Beyond the preview
Go deeper on NCT02899611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02899611.